Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1217Neoplasms 1033Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 688Colorectal Neoplasms 593Lung Neoplasms 575Pancreatic Neoplasms 407Leukemia, Myeloid, Acute 396Neoplasm Metastasis 382Multiple Myeloma 373Ovarian Neoplasms 369Stomach Neoplasms 322Carcinoma, Hepatocellular 301Recurrence 281Melanoma 281Brain Neoplasms 274Squamous Cell Carcinoma of Head and Neck 269Endometrial Neoplasms 234Head and Neck Neoplasms 232Triple Negative Breast Neoplasms 231Precursor Cell Lymphoblastic Leukemia-Lymphoma 227Lymphoma 227Glioblastoma 225Uterine Cervical Neoplasms 222Sarcoma 201Hematologic Neoplasms 201Urinary Bladder Neoplasms 196Esophageal Neoplasms 192Carcinoma, Renal Cell 190Lymphoma, Non-Hodgkin 176

Interventions

Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Resectable Rectal Cancer × 1 year × Clear all
NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 2/3 Recruiting
165 enrolled
Gastrointestinal

Locally Advanced Resectable Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡